Dcf Advisers, LLC Evotec Se Transaction History
Dcf Advisers, LLC
- $185 Million
- Q2 2024
A detailed history of Dcf Advisers, LLC transactions in Evotec Se stock. As of the latest transaction made, Dcf Advisers, LLC holds 114,953 shares of EVO stock, worth $526,484. This represents 0.3% of its overall portfolio holdings.
Number of Shares
114,953
Previous 47,797
140.5%
Holding current value
$526,484
Previous $374,000
47.33%
% of portfolio
0.3%
Previous 0.19%
Shares
5 transactions
Others Institutions Holding EVO
# of Institutions
32Shares Held
2.86MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA2.03MShares$9.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny192KShares$877,1980.0% of portfolio
-
Mediolanum International Funds LTD Dublin 1, L2140KShares$642,9540.01% of portfolio
-
Morgan Stanley New York, NY122KShares$557,8890.0% of portfolio
-
Black Rock Inc. New York, NY82.6KShares$378,2980.0% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.62B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...